Participants
PD
TUMOURS, DISEASES, CHRONIC PANCREATITIS, ACUTE NECROTIZING PANCREATITIS
This study assessed for eligibility consecutive patients selected for undergoing PD with benign or malignant periampullary tumours or benign diseases (that is chronic pancreatitis) with a pancreatojejunostomy (PJ) reconstruction, male and female patients, between 18 and 80 years of age, with an ASA Physical Status Classification SystemPatients were excluded if they had any contraindication for performing PD, had acute necrotizing pancreatitis, had immune suppression, were unwilling to comply with the investigators and protocol indications, were incapable of providing written consent, had an ASA grade of greater than or equal to IV, had received neoadjuvant treatment, and required vascular resection during surgery. Data were collected and managed using Research Electronic Data Capture (REDCap, Vanderbilt University, Nashville, TN, USA). The patient cases were discussed in a multidisciplinary committee and surgery procedure was decided. Subsequently, once the patient was informed by any of the three surgeons responsible for performing the surgeries and had signed the informed consent, they were recruited for the trial.